Resveratrol has been shown to inhibit NF-κB activation by suppressing protein kinase C-β2 (PKC-β2) phosphorylation, reducing downstream target gene expression, including iNOS, COX-2, and aldose reductase in AOM-stimulated mouse colon tissues [72]. Here, AKR1B1 is linked to infectious otitis media.